Menu
Back to Journals » Clinical Ophthalmology » Volume 4
Original Research
Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,459 | Dovepress* | 9,459+ | 2,013 | 11,472 | |
| Totals | 9,459 | 2,013 | 11,472 | ||
|
*Since 8 April 2010 +Since July 2016 |
|||||
View citations on Google Scholar